Each year, millions of people suffer from some kind of medical condition, from autoimmune diseases like diabetes to viruses like COVID-19. Drug companies race to come up with treatment options, but more than 80% of clinical drug trials for life saving drugs are still being done with pen and paper. Even more frustrating is that COVID-19 has flipped the clinical trial industry on its head with a massive transition to remote clinical trials. Imagine what it would look like if you could apply IoT and automation to clinical drug trials, thus achieving remote clinical trials while speeding up the availability of medications.
In this webinar, Dylan Swartz, Developer Advocate at Mason will share how they are using their cellular-enabled tablets plus intelligent software to make it easier for pharmaceutical companies to bring life saving drugs (such as the COVID-19 vaccine) to market faster. Product managers and developers who are creating telemedicine and pharmaceutical solutions will leave the webinar feeling more confident in relying on cellular connected hardware solutions for their applications.
What you’ll hear in the webinar:
- How can you transform clinical trials with a DevOps methodology and interactive IoT devices?
- How does Mason use IoT to help pharmaceutical companies conduct clinical drug trials?
- How does Mason leverage Twilio to rapidly deploy interactive clinical trial devices?